Live Breaking News & Updates on Theralink Assay

Stay updated with breaking news from Theralink assay. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Theralink® Acquires Exclusive Landmark Immunotherapy Patent including Biomarker from Vanderbilt University

/PRNewswire/ Theralink Technologies, Inc. (OTC: THER) ("Theralink" or the "Company"), a precision oncology company with a novel phosphoprotein and protein. ....

United States , Mick Ruxin , Emanuel Petricoin , Justin Balko , Theralink Technologies Inc , Prnewswire Theralink Technologies Inc , Vanderbilt University Medical Center , Vanderbilt University , Science Advisory Board , Associate Professor , Theralink Assay , Patent Details , Theralink Technologies , Reverse Phase Protein Array ,

Telo Genomics Appoints Kris Weinberg as Chief Executive Officer

Telo Genomics Appoints Kris Weinberg as Chief Executive Officer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

John Meekison , Hugh Rogers , Guardant Health , Mars Centre , Genomic Health , Audit Committee , Newsfile Corp , Technology Officer , Telo Genomics Corp , Regulation Services Provider , Venture Exchange , Kris Weinberg , Chief Executive Officer , Sherif Louis Phd , Chief Technology , Telo Genomics Board Director , Theralink Technologies , Theralink Assay , Breast Cancer , Telo Genomic , South Tower ,

Theralink® Technologies Accepted to Present Two Posters at the Upcoming San Antonio Breast Cancer Symposium

/PRNewswire/ Theralink Technologies (OTC: THER) ("Theralink" or the "Company"), a precision oncology company with a novel quantitative protein and. ....

United States , San Antonio , Mick Ruxin , Theralink Technologies Inc , Program Number , Reverse Phase Protein Array , San Antonio Breast Cancer Symposium , Theralink Technologies , Theralink Assay , Advanced Breast Cancer , Poster Presentation , Novel Quantitative , Determining Dynamic , Precision Therapy , Special Session , Phosphoprotein Assay , Treatment Selection , Routine Clinical Practice , Prospective Observational Study , Advance Breast Cancer , Poster Session ,

Theralink® Acquires Two New Milestone Patents Relating to Methods for Treating Breast Cancer

/PRNewswire/ Theralink Technologies, Inc. (OTC: THER) ("Theralink" or the "Company"), a precision oncology company with a novel phosphoprotein-based assay. ....

United States , Emanuel Petricoin , Mick Ruxin , George Mason University , Theralink Technologies Inc , Phase Protein Array Technology , Predictive Biomarker Patents , Breast Cancer , Theralink Technologies , Science Advisory Board , Reverse Phase Protein Array Technology , Theralink Assay , Patent Details , Treating Breast Cancer , Reverse Phase Protein Array ,